Volume 22, Number 2—February 2016
Research
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
Table 2
Timing of steps in Xpert Ebola Assay for blood samples collected at Médecins Sans Frontières Donka Ebola Treatment Center, Conakry, Guinea, May–June 2015*
Step | Median (IQR), min |
---|---|
Sampling obtained to sample received at laboratory† | 11 (5–20) |
Sample received to inactivation | 14 (8–28) |
Inactivation to start of assay | 49 (43–56) |
Start of assay to end of assay | 94 (94–95) |
End of assay to result available | 2 (1–8) |
*IQR, interquartile range.
†Only 67 samples were included; time of collection was not recorded for other samples.
Page created: January 13, 2016
Page updated: January 13, 2016
Page reviewed: January 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.